| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1001888121 |
| P356 | DOI | 10.1186/S12936-015-0567-9 |
| P932 | PMC publication ID | 4332451 |
| P698 | PubMed publication ID | 25653026 |
| P5875 | ResearchGate publication ID | 272080977 |
| P50 | author | Ogobara K. Doumbo | Q3349810 |
| Robert W Sauerwein | Q60043950 | ||
| Bourèma Kouriba | Q91963584 | ||
| Issa Diarra | Q109742476 | ||
| Modibo Daou | Q114367985 | ||
| Charles Arama | Q114406027 | ||
| Yamoussa Keita | Q125294324 | ||
| Sibiri Sissoko | Q125294478 | ||
| Anja Scholzen | Q42846768 | ||
| Teun Bousema | Q44168464 | ||
| P2093 | author name string | Boucary Ouologuem | |
| Nicolas Ouédraogo | |||
| Seydou Arama | |||
| P2860 | cites work | A review of malaria vaccine clinical projects based on the WHO rainbow table | Q21034112 |
| Shrinking the malaria map: progress and prospects | Q24614679 | ||
| Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age | Q24658073 | ||
| A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites | Q27973519 | ||
| Primary structure and localization of a conserved immunogenicPlasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle | Q27974520 | ||
| Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material | Q28289686 | ||
| Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants | Q28303270 | ||
| Evidence-based annotation of the malaria parasite's genome using comparative expression profiling | Q28472095 | ||
| Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite | Q30039115 | ||
| Complete Plasmodium falciparum liver-stage development in liver-chimeric mice | Q30525395 | ||
| The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis | Q33526349 | ||
| The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections | Q33587496 | ||
| A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray | Q33859633 | ||
| Parasite burden and severity of malaria in Tanzanian children | Q33882158 | ||
| High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion | Q34129066 | ||
| Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii | Q34183154 | ||
| Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children | Q34261333 | ||
| Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya | Q34541443 | ||
| New antigens for a multicomponent blood-stage malaria vaccine | Q35216634 | ||
| Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens | Q35264640 | ||
| Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial | Q35925829 | ||
| The complexities of malaria disease manifestations with a focus on asymptomatic malaria | Q35930447 | ||
| Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. | Q54638975 | ||
| Serological Reactivity of in Vitro Cultured Exoerythrocytic Stages of Plasmodium Berghei in Indirect Immunofluorescent or Immunoperoxidase Antibody Tests | Q70240120 | ||
| Maintenance of serum antibody levels | Q36072426 | ||
| Allelic forms of gp195, a major blood-stage antigen of Plasmodium falciparum, are expressed in liver stages | Q36354328 | ||
| A combined transcriptome and proteome survey of malaria parasite liver stages | Q36423509 | ||
| Factors determining the occurrence of submicroscopic malaria infections and their relevance for control | Q36503207 | ||
| Standardization and validation of a cytometric bead assay to assess antibodies to multiple Plasmodium falciparum recombinant antigens | Q36539299 | ||
| Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria | Q36594057 | ||
| Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children | Q36862490 | ||
| A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria | Q37148056 | ||
| Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial | Q37182225 | ||
| Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure | Q37191417 | ||
| Immunization with apical membrane antigen 1 confers sterile infection-blocking immunity against Plasmodium sporozoite challenge in a rodent model. | Q37264651 | ||
| What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity | Q37413044 | ||
| Naturally acquired immune responses against Plasmodium falciparum sporozoites and liver infection | Q38007787 | ||
| Influence of infection on malaria-specific antibody dynamics in a cohort exposed to intense malaria transmission in northern Uganda | Q38865826 | ||
| Asymptomatic parasitaemia as a risk factor for symptomatic malaria in a cohort of Ugandan children | Q38881807 | ||
| Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection | Q39362543 | ||
| Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. | Q39417737 | ||
| What is clinical malaria? Finding case definitions for field research in highly endemic areas | Q39435655 | ||
| Longevity of naturally acquired antibody responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1. | Q41923301 | ||
| Protection against a malaria challenge by sporozoite inoculation | Q41937865 | ||
| IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life | Q42151954 | ||
| Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection | Q43933739 | ||
| Asymptomatic malaria infections: detectability, transmissibility and public health relevance | Q44146283 | ||
| The importance of sensitive detection of malaria parasites in the human and insect hosts in epidemiological studies, as shown by the analysis of field samples from Guinea Bissau | Q44171911 | ||
| Production, quality control, stability and pharmacotoxicity of cGMP-produced Plasmodium falciparum AMA1 FVO strain ectodomain expressed in Pichia pastoris | Q46135488 | ||
| Analysis of antigen-specific antibodies and their isotypes in experimental malaria | Q46303742 | ||
| Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. | Q46334562 | ||
| Epidemiology of malaria in a village of Sudanese savannah area in Mali (Bancoumana). 2. Entomo-parasitological and clinical study | Q46428665 | ||
| Expression of the precursor of the major merozoite surface antigens during the hepatic stage of malaria | Q46961537 | ||
| Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications | Q47911975 | ||
| Gamma-globulin and acquired immunity to human malaria | Q47957467 | ||
| The distribution of Plasmodium falciparum infection durations | Q47981171 | ||
| Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections | Q47997112 | ||
| Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection. | Q48012112 | ||
| Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes | Q48013154 | ||
| Development and evaluation of a multiplex screening assay for Plasmodium falciparum exposure | Q48015973 | ||
| Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial | Q48034345 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Mali | Q912 |
| malaria | Q12156 | ||
| P304 | page(s) | 56 | |
| P577 | publication date | 2015-02-05 | |
| P1433 | published in | Malaria Journal | Q15749954 |
| P1476 | title | Protection of Malian children from clinical malaria is associated with recognition of multiple antigens | |
| P478 | volume | 14 |
| Q40102134 | Acquisition, maintenance and adaptation of invasion inhibitory antibodies against Plasmodium falciparum invasion ligands involved in immune evasion |
| Q33909630 | An analytical approach to reduce between-plate variation in multiplex assays that measure antibodies to Plasmodium falciparum antigens |
| Q37129874 | Chemically Attenuated Blood-Stage Plasmodium yoelii Parasites Induce Long-Lived and Strain-Transcending Protection |
| Q47311278 | EDiP: the Epitope Dilution Phenomenon. Lessons learnt from a malaria vaccine antigen and its applicability to polymorphic antigens |
| Q55248535 | Factors influencing the induction of high affinity antibodies to Plasmodium falciparum merozoite antigens and how affinity changes over time. |
| Q38689264 | Immunity to malaria in an era of declining malaria transmission |
| Q97546189 | Proteome-wide analysis of a malaria vaccine study reveals personalized humoral immune profiles in Tanzanian adults |
| Q36331757 | T cell subtypes and reciprocal inflammatory mediator expression differentiate P. falciparum memory recall responses in asymptomatic and symptomatic malaria patients in southeastern Haiti |
| Q41994486 | Variations in the quality of malaria-specific antibodies with transmission intensity in a seasonal malaria transmission area of Northern Ghana |
Search more.